Related Experiment Video
Updated: Mar 18, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
Antiatherogenic Roles of Dietary Flavonoids Chrysin, Quercetin, and Luteolin
Anandita Basu1, Anindhya S Das, Munmi Majumder
1Department of Molecular Biology and Biotechnology, Tezpur University, Napaam, India.
Insights
Cardiovascular diseases (CVDs) are a leading cause of death. This review explores how anti-inflammatory flavonoids like chrysin, quercetin, and luteolin may combat atherosclerosis, a key factor in CVDs.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Natural Products
Background:
- Cardiovascular diseases (CVDs) represent a significant global health burden, with atherosclerosis as a primary pathological process.
- Current management of atherosclerosis, particularly preventive and therapeutic interventions, remains suboptimal.
- Aberrant lipid metabolism and chronic inflammation are key drivers in atherosclerosis development and progression.
Purpose of the Study:
- To review the potential antiatherogenic effects of specific flavonoids.
- To highlight the role of anti-inflammatory properties of flavonoids in managing atherosclerosis.
- To discuss chrysin, quercetin, and luteolin as potential therapeutic agents against atherosclerosis.
Main Methods:
- Literature review focusing on anti-inflammatory flavonoids.
- Analysis of studies investigating the impact of flavonoids on lipid metabolism and inflammation.
- Examination of research on chrysin, quercetin, and luteolin in the context of atherosclerosis.
Main Results:
- Flavonoids possess significant anti-inflammatory properties.
- These anti-inflammatory actions are crucial for managing atherosclerosis.
- Chrysin, quercetin, and luteolin show promise in combating atherosclerosis through their anti-inflammatory mechanisms.
Conclusions:
- Controlling inflammation is a critical, yet often overlooked, aspect of atherosclerosis management.
- Plant-derived flavonoids, specifically chrysin, quercetin, and luteolin, offer a promising avenue for antiatherogenic therapy.
- Targeting inflammation with these flavonoids could lead to more effective treatment strategies for cardiovascular diseases.
Abstract:
Cardiovascular diseases (CVDs) are the commonest cause of global mortality and morbidity. Atherosclerosis, the fundamental pathological manifestation of CVDs, is a complex process and is poorly managed both in terms of preventive and therapeutic intervention. Aberrant lipid metabolism and chronic inflammation play critical roles in the development of atherosclerosis. These processes can be targeted for effective management of the disease. Although managing lipid metabolism is in the forefront of current therapeutic approaches, controlling inflammation may also prove to be crucial for an efficient treatment regimen of the disease. Flavonoids, the plant-derived polyphenols, are known for their antiinflammatory properties. This review discusses the possible antiatherogenic role of 3 flavonoids, namely, chrysin, quercetin, and luteolin primarily known for their antiinflammatory properties.
More Related Videos
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Cancer Prevention
Some...
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures